|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:MED13-C20orf118 (FusionGDB2 ID:52553) |
Fusion Gene Summary for MED13-C20orf118 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: MED13-C20orf118 | Fusion gene ID: 52553 | Hgene | Tgene | Gene symbol | MED13 | C20orf118 | Gene ID | 9969 | 140711 |
| Gene name | mediator complex subunit 13 | TBC/LysM-associated domain containing 2 | |
| Synonyms | ARC250|DRIP250|HSPC221|MRD61|THRAP1|TRAP240 | C20orf118 | |
| Cytomap | 17q23.2 | 20q11.23 | |
| Type of gene | protein-coding | protein-coding | |
| Description | mediator of RNA polymerase II transcription subunit 13activator-recruited cofactor 250 kDa componentmediator of RNA polymerase II transcription, subunit 13 homologthyroid hormone receptor-associated protein 1thyroid hormone receptor-associated protein | TLD domain-containing protein 2TBC/LysM-associated domain-containing protein 2 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q9UHV7 | . | |
| Ensembl transtripts involved in fusion gene | |||